Re: OTC Expert & Grey Market Restrictions
in response to
by
posted on
Nov 22, 2022 03:40PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Have you tried to purchase any ZHCLF in the past year through TD?